Furthermore, the company did not make a loss from operations in 2020FY.
Straight from the 2020 results announcement:
"Of note within the Company’s first financial results performance after going through a significant start-up phase, the Company was able to generate net cash from operating activities of $1.99 million."
Considering the acquisition was only completed in September, turning a $2m profit from operations in 9 months is an exceptional result. How many companies on the ASX spend years chasing to be cashflow positive? Vysarn were cashflow positive from November (as per announcement in Feb 2020), a mere 3 months from start up.
Also note that previous announcements they have been very conservative on projected earnings. For now, they have only added a footnote stating "management also anticipate that a material outperformance of this EBITDA (6.03m) benchmark is possible if several earmarked multi-rig, multi-year contracts are won leading into the June half of FY2021."
But as for my previous posts, while the share price is currently supportive of current operations, the value in Vysarn is in their growth story.
- Forums
- ASX - By Stock
- VYS
- Ann: Investor Presentation September 2020
Ann: Investor Presentation September 2020, page-35
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VYS (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.3¢ |
Change
0.003(0.53%) |
Mkt cap ! $243.1M |
Open | High | Low | Value | Volume |
49.0¢ | 49.0¢ | 46.5¢ | $177.4K | 372.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 12812 | 47.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 34760 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 59497 | 0.465 |
5 | 73100 | 0.460 |
2 | 11779 | 0.455 |
6 | 28976 | 0.450 |
6 | 39849 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 37660 | 7 |
0.480 | 58594 | 6 |
0.485 | 33986 | 6 |
0.490 | 34443 | 6 |
0.495 | 133559 | 5 |
Last trade - 10.28am 12/11/2024 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online